NCT03178942: A trial that was reported late by Encube Ethicals Pvt. Ltd.
This trial has reported, although it was 96 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03178942 |
|---|---|
| Title | A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% (Encube Ethicals) Compared to Elimite™ Cream (Permethrin) 5% (Prestium Pharma, Inc.) in the Treatment of Scabies |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 1, 2017 |
| Completion date | Nov. 11, 2017 |
| Required reporting date | Nov. 11, 2018, midnight |
| Actual reporting date | Feb. 15, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 96 |